Follow-up Study in French Practice to Evaluate Improvements in Walking and Pain Relief in Patients Treated With Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon

NAActive, not recruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

December 4, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Drug-coated Balloon Catheter
Interventions
OTHER

6-minute walk test

6-minute walk test

OTHER

WIQ functional questionnaire

WIQ functional questionnaire

OTHER

quality of life questionnaires (EQ5D5L and SF-36)

quality of life questionnaires (EQ5D5L and SF-36)

Trial Locations (1)

21000

Chu Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER